Reply to Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer: Limitations of the VISION trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.022 Editorial

  

Authors:	Morris, M. J.; Sartor, O.; de Bono, J. S.; Fizazi, K.; Tagawa, S. T.
Title:	Reply to Timothée Olivier, Kerrington Powell, Vinay Prasad. Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer: Limitations of the VISION trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.022
Journal Title:	European Urology
Volume:	84
Issue:	1
ISSN:	0302-2838
Publisher:	Elsevier Science, Inc.
Date Published:	2023-07-01
Start Page:	7
End Page:	8
Language:	English
DOI:	10.1016/j.eururo.2023.03.028
PUBMED:	37032186
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85151864916&doi=10.1016%2fj.eururo.2023.03.028&partnerID=40&md5=5511e816292d761b46aee59ddac8d5ce
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/207265